Characterization of the A673 cell line (Ewing tumor) by molecular cytogenetic techniques

Cancer Genet Cytogenet. 2003 Mar;141(2):138-42. doi: 10.1016/s0165-4608(02)00670-2.

Abstract

The A673 cell line was established from a patient with a primary rhabdomyosarcoma (RMS), which is referred to in the literature either as a Ewing tumor (ET) or as RMS. Although the two tumoral types are associated with specific and well-characterized translocations, no cytogenetic report on this cell line has been published. We characterized the A673 cell line using a combination of spectral karyotyping (SKY), fluorescence in situ hybridization (FISH), and reverse transcriptase polymerase chain reaction (RT-PCR), which revealed the presence of a complex karyotype and a translocation involving chromosomes 11 and 22 and the fusion of EWS and FLI1 genes, both events being specific to ET. Neither cytogenetics nor molecular alterations specific to RMS were found.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chromosome Aberrations*
  • DNA-Binding Proteins / genetics
  • Forkhead Box Protein O1
  • Forkhead Transcription Factors
  • Homeodomain Proteins / genetics
  • Humans
  • In Situ Hybridization, Fluorescence
  • Karyotyping
  • PAX7 Transcription Factor
  • Proto-Oncogene Protein c-fli-1
  • Proto-Oncogene Proteins*
  • RNA-Binding Protein EWS / genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • Rhabdomyosarcoma / genetics*
  • Rhabdomyosarcoma / pathology
  • Sarcoma, Ewing / genetics*
  • Trans-Activators / genetics
  • Transcription Factors / genetics
  • Translocation, Genetic
  • Tumor Cells, Cultured

Substances

  • DNA-Binding Proteins
  • FOXO1 protein, human
  • Forkhead Box Protein O1
  • Forkhead Transcription Factors
  • Homeodomain Proteins
  • PAX7 Transcription Factor
  • Proto-Oncogene Protein c-fli-1
  • Proto-Oncogene Proteins
  • RNA-Binding Protein EWS
  • Trans-Activators
  • Transcription Factors